Amber D. Steele

Array ( [id] => 6620889 [patent_doc_number] => 20100003542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Coating of artificial surfaces of medical aids and instruments, and cleaning and/or pretreatment of catheters and other medical aids and instruments' [patent_app_type] => utility [patent_app_number] => 12/375016 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5542 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003542.pdf [firstpage_image] =>[orig_patent_app_number] => 12375016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257268 [patent_doc_number] => 20100029627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'MTKI QUINAZOLINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/373404 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27907 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029627.pdf [firstpage_image] =>[orig_patent_app_number] => 12373404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374733 [patent_doc_number] => 20090312294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Method and Agent for Reducing Weight, Accelerating Lipid Catabolism, and/or Restricting Calories' [patent_app_type] => utility [patent_app_number] => 12/307444 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4011 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312294.pdf [firstpage_image] =>[orig_patent_app_number] => 12307444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6306707 [patent_doc_number] => 20100069350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'New Pyridine Analogues III' [patent_app_type] => utility [patent_app_number] => 12/307277 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56464 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069350.pdf [firstpage_image] =>[orig_patent_app_number] => 12307277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6219999 [patent_doc_number] => 20100055094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'PHARMACEUTICAL COMBINATIONS OF 1-CYCLOPROPYL-3- [3-(5-M0RPHOOLIN-4-YL-METHYL-1H-BENZOIMIDAZOL-2-YL)- LH-1-PYRAZOL-4-YL]- UREA' [patent_app_type] => utility [patent_app_number] => 12/306479 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 101180 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055094.pdf [firstpage_image] =>[orig_patent_app_number] => 12306479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638057 [patent_doc_number] => 20100035955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Stabilised Composition Comprising ACE Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/307029 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3350 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035955.pdf [firstpage_image] =>[orig_patent_app_number] => 12307029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230776 [patent_doc_number] => 20070292883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Method of treating diseases with PARP inhibitors' [patent_app_type] => utility [patent_app_number] => 11/818210 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 49256 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292883.pdf [firstpage_image] =>[orig_patent_app_number] => 11818210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230776 [patent_doc_number] => 20070292883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Method of treating diseases with PARP inhibitors' [patent_app_type] => utility [patent_app_number] => 11/818210 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 49256 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292883.pdf [firstpage_image] =>[orig_patent_app_number] => 11818210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153705 [patent_doc_number] => 08586612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them' [patent_app_type] => utility [patent_app_number] => 11/761565 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12159 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11761565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638324 [patent_doc_number] => 20100173935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer\'s Disease and Schizophrenia' [patent_app_type] => utility [patent_app_number] => 12/303641 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24305 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173935.pdf [firstpage_image] =>[orig_patent_app_number] => 12303641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527849 [patent_doc_number] => 20090197926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'BENZIMIDAZOLES AND THEIR USE FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/303512 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26638 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197926.pdf [firstpage_image] =>[orig_patent_app_number] => 12303512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682232 [patent_doc_number] => 20100022576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'STABLE AND BIOAVAILABLE FORMULATIONS AND A NOVEL FORM OF DESLORATADINE' [patent_app_type] => utility [patent_app_number] => 12/375038 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4086 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022576.pdf [firstpage_image] =>[orig_patent_app_number] => 12375038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527851 [patent_doc_number] => 20090197928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Novel Receptor Antagonists and Their Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/303262 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7495 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197928.pdf [firstpage_image] =>[orig_patent_app_number] => 12303262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546738 [patent_doc_number] => 20090156615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/303490 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51216 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156615.pdf [firstpage_image] =>[orig_patent_app_number] => 12303490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658185 [patent_doc_number] => 20080027047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Compounds that modulate HSP90 activity and methods for identifying same' [patent_app_type] => utility [patent_app_number] => 11/807351 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 61865 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027047.pdf [firstpage_image] =>[orig_patent_app_number] => 11807351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5084874 [patent_doc_number] => 20070274925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'NEBULIZABLE COMPOSITIONS OF QUATERNARY AMMONIUM MUSCARINIC RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/753648 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8587 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274925.pdf [firstpage_image] =>[orig_patent_app_number] => 11753648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786216 [patent_doc_number] => 20080139545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'FORMULATION TO TREAT EAR INFECTION' [patent_app_type] => utility [patent_app_number] => 11/752087 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16689 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139545.pdf [firstpage_image] =>[orig_patent_app_number] => 11752087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343300 [patent_doc_number] => 20090181950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Histamine Receptor Antagonists Comprising an Azepin Core' [patent_app_type] => utility [patent_app_number] => 12/300832 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22331 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181950.pdf [firstpage_image] =>[orig_patent_app_number] => 12300832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758936 [patent_doc_number] => 20080311162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Solid form' [patent_app_type] => utility [patent_app_number] => 11/803825 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10558 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311162.pdf [firstpage_image] =>[orig_patent_app_number] => 11803825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586083 [patent_doc_number] => 20090105285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'PHARMACEUTICAL COMBINATIONS COMPRISING A MTOR INHIBITOR AND A RAF KINASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/299819 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17526 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105285.pdf [firstpage_image] =>[orig_patent_app_number] => 12299819 [rel_patent_id] =>[rel_patent_doc_number] =>)